ETV6-NTRK3 Fusion Oncogene Initiates Breast Cancer from Committed Mammary Progenitors via Activation of AP1 Complex

Cancer Cell

Volumn 12, Issue 6, 2007, Pages 542-558

  Li, Zhe ^a,d,e   Tognon, Cristina E ^f   Godinho, Frank J ^a,c   Yasaitis, Laura ^a   Hock, Hanno ^a,d,e   Herschkowitz, Jason I ^g   Lannon, Chris L ^f   Cho, Eunah ^h   Kim, Seong Jin ^h   Bronson, Roderick T ^d   Perou, Charles M ^g   Sorensen, Poul H ^f   Orkin, Stuart H ^a,b,c,d,e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HARVARD STEM CELL INSTITUTE   (United States)

^f BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

CELLCYCLE; STEMCELL

Indexed keywords

GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR NTRK3; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST; BREAST CANCER; CARCINOGENESIS; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FACIAL EXPRESSION; GENETICS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

MUS;

EID: 36649021126     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.11.012     Document Type: Article

References (56)

1. Asselin-Labat M.L., Sutherland K.D., Barker H., Thomas R., Shackleton M., Forrest N.C., Hartley L., Robb L., Grosveld F.G., van der Wees J., et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat. Cell Biol. 9 (2007) 201-209
2. Bakiri L., Lallemand D., Bossy-Wetzel E., and Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: A role in the control of cyclin D1 expression. EMBO J. 19 (2000) 2056-2068
3. Belguise K., Kersual N., Galtier F., and Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24 (2005) 1434-1444
4. Booth B.W., Boulanger C.A., and Smith G.H. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. J. Cell. Physiol. 212 (2007) 729-736
5. Boulanger C.A., Wagner K.U., and Smith G.H. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 24 (2005) 552-560
6. Chiappetta G., Ferraro A., Botti G., Monaco M., Pasquinelli R., Vuttariello E., Arnaldi L., Di Bonito M., D'Aiuto G., Pierantoni G.M., and Fusco A. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 7 (2007) 17
7. Eferl R., and Wagner E.F. AP-1: A double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
8. Eguchi M., Eguchi-Ishimae M., Tojo A., Morishita K., Suzuki K., Sato Y., Kudoh S., Tanaka K., Setoyama M., Nagamura F., et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93 (1999) 1355-1363
9. Euhus D.M., Timmons C.F., and Tomlinson G.E. ETV6-NTRK3-Trk-ing the primary event in human secretory breast cancer. Cancer Cell 2 (2002) 347-348
10. Hennighausen L., and Robinson G.W. Information networks in the mammary gland. Nat. Rev. Mol. Cell Biol. 6 (2005) 715-725
11. Henry M.D., Triplett A.A., Oh K.B., Smith G.H., and Wagner K.U. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-neu transgenic mice. Oncogene 23 (2004) 6980-6985
12. Herschkowitz J.I., Simin K., Weigman V.J., Mikaelian I., Usary J., Hu Z., Rasmussen K.E., Jones L.P., Assefnia S., Chandrasekharan S., et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8 (2007) R76
13. Ince T.A., Richardson A.L., Bell G.W., Saitoh M., Godar S., Karnoub A.E., Iglehart J.D., and Weinberg R.A. Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell 12 (2007) 160-170
14. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351 (2004) 657-667
15. Knezevich S.R., Garnett M.J., Pysher T.J., Beckwith J.B., Grundy P.E., and Sorensen P.H. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 58 (1998) 5046-5048
16. Knezevich S.R., McFadden D.E., Tao W., Lim J.F., and Sorensen P.H. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 18 (1998) 184-187
17. Kordon E.C., McKnight R.A., Jhappan C., Hennighausen L., Merlino G., and Smith G.H. Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev. Biol. 168 (1995) 47-61
18. Krivtsov A.V., Twomey D., Feng Z., Stubbs M.C., Wang Y., Faber J., Levine J.E., Wang J., Hahn W.C., Gilliland D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006) 818-822
19. Lamb R.F., Hennigan R.F., Turnbull K., Katsanakis K.D., MacKenzie E.D., Birnie G.D., and Ozanne B.W. AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44. Mol. Cell. Biol. 17 (1997) 963-976
20. Li Y., and Rosen J.M. Stem/progenitor cells in mouse mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 10 (2005) 17-24
21. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98 (2001) 31-36
22. Liu Y., Ludes-Meyers J., Zhang Y., Munoz-Medellin D., Kim H.T., Lu C., Ge G., Schiff R., Hilsenbeck S.G., Osborne C.K., and Brown P.H. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 21 (2002) 7680-7689
23. Lobo N.A., Shimono Y., Qian D., and Clarke M.F. The biology of cancer stem cells. Annu. Rev. Cell Dev. Biol. 23 (2007) 675-699
24. Ludes-Meyers J.H., Liu Y., Munoz-Medellin D., Hilsenbeck S.G., and Brown P.H. AP-1 blockade inhibits the growth of normal and malignant breast cells. Oncogene 20 (2001) 2771-2780
25. Luo Y., Zhou H., Mizutani M., Mizutani N., Reisfeld R.A., and Xiang R. Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine. Proc. Natl. Acad. Sci. USA 100 (2003) 8850-8855
26. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., and Hanski C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 96 (1999) 1603-1608
27. Mao X., Fujiwara Y., and Orkin S.H. Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc. Natl. Acad. Sci. USA 96 (1999) 5037-5042
28. Meyerson M. Cancer: Broken genes in solid tumours. Nature 448 (2007) 545-546
29. Milde-Langosch K., Bamberger A.M., Rieck G., Kelp B., and Loning T. Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype. Breast Cancer Res. Treat. 67 (2001) 61-70
30. Milde-Langosch K., Roder H., Andritzky B., Aslan B., Hemminger G., Brinkmann A., Bamberger C.M., Loning T., and Bamberger A.M. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res. Treat. 86 (2004) 139-152
31. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
32. Robinson G.W., McKnight R.A., Smith G.H., and Hennighausen L. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121 (1995) 2079-2090
33. Robinson G.W., Smith G.H., Gallahan D., Zimmer A., Furth P.A., and Hennighausen L. Understanding mammary gland development through the imbalanced expression of growth regulators. Dev. Dyn. 206 (1996) 159-168
34. Rowley J.D. Chromosome translocations: Dangerous liaisons revisited. Nat. Rev. Cancer 1 (2001) 245-250
35. Rubin B.P., Chen C.J., Morgan T.W., Xiao S., Grier H.E., Kozakewich H.P., Perez-Atayde A.R., and Fletcher J.A. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: Cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am. J. Pathol. 153 (1998) 1451-1458
36. Safran M., Kim W.Y., Kung A.L., Horner J.W., DePinho R.A., and Kaelin Jr. W.G. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol. Imaging 2 (2003) 297-302
37. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., and Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 439 (2006) 84-88
38. Shen Q., Zhang Y., Uray I.P., Hill J.L., Kim H.T., Lu C., Young M.R., Gunther E.J., Hilsenbeck S.G., Chodosh L.A., et al. The AP-1 transcription factor regulates postnatal mammary gland development. Dev. Biol. 295 (2006) 589-603
39. Shen Q., Uray I.P., Li Y., Krisko T.I., Strecker T.E., Kim H.T., and Brown P.H. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Oncogene (2007) 10.1038/sj.onc.1210643 Published online July 16, 2007
40. Simpson P.T., Reis-Filho J.S., Gale T., and Lakhani S.R. Molecular evolution of breast cancer. J. Pathol. 205 (2005) 248-254
41. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S.I., Watanabe H., Kurashina K., Hatanaka H., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448 (2007) 561-566
42. Sorlie T., Perou C.M., Tibshirani R., Aas T., Geisler S., Johnsen H., Hastie T., Eisen M.B., van de Rijn M., Jeffrey S.S., et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98 (2001) 10869-10874
43. Stingl J., Eirew P., Ricketson I., Shackleton M., Vaillant F., Choi D., Li H.I., and Eaves C.J. Purification and unique properties of mammary epithelial stem cells. Nature 439 (2006) 993-997
44. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., and Mesirov J.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005) 15545-15550
45. Tognon C., Garnett M., Kenward E., Kay R., Morrison K., and Sorensen P.H. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res. 61 (2001) 8909-8916
46. Tognon C., Knezevich S.R., Huntsman D., Roskelley C.D., Melnyk N., Mathers J.A., Becker L., Carneiro F., MacPherson N., Horsman D., et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2 (2002) 367-376
47. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., Varambally S., Cao X., Tchinda J., Kuefer R., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 (2005) 644-648
48. Tomlins S.A., Mehra R., Rhodes D.R., Smith L.R., Roulston D., Helgeson B.E., Cao X., Wei J.T., Rubin M.A., Shah R.B., and Chinnaiyan A.M. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res. 66 (2006) 3396-3400
49. Tomlins S.A., Laxman B., Dhanasekaran S.M., Helgeson B.E., Cao X., Morris D.S., Menon A., Jing X., Cao Q., Han B., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448 (2007) 595-599
50. Utomo A.R., Nikitin A.Y., and Lee W.H. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 17 (1999) 1091-1096
51. Vleugel M.M., Greijer A.E., Bos R., van der Wall E., and van Diest P.J. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37 (2006) 668-674
52. Wagner K.U., Wall R.J., St-Onge L., Gruss P., Wynshaw-Boris A., Garrett L., Li M., Furth P.A., and Hennighausen L. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25 (1997) 4323-4330
53. Wagner K.U., Boulanger C.A., Henry M.D., Sgagias M., Hennighausen L., and Smith G.H. An adjunct mammary epithelial cell population in parous females: Its role in functional adaptation and tissue renewal. Development 129 (2002) 1377-1386
54. Wagner K.U., and Smith G.H. Pregnancy and stem cell behavior. J. Mammary Gland Biol. Neoplasia 10 (2005) 25-36
55. Wai D.H., Knezevich S.R., Lucas T., Jansen B., Kay R.J., and Sorensen P.H. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 19 (2000) 906-915
56. Welm B.E., Tepera S.B., Venezia T., Graubert T.A., Rosen J.M., and Goodell M.A. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245 (2002) 42-56